Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1486, 2005-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Torasemide, but not furosemide may have additional benefit in CHF
Inpharma, Vol. 1, Iss. 1443, 2004-01 ,pp. :
Low- vs high-dose cyclophosphamide in lupus nephritis
Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. :
Torasemide outshines furosemide in QOL stakes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. :
High-dose vs approved-dose fulvestrant for ER+ breast cancer
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :